Placental function, fetal distress, and the fetal/placental weight ratio in normal and gestotic pregnancies. 1982

P Riss, and W Bartl

The ratio between fetal and placental weight is often thought to be a measure of the reserve capacity of the placenta. The aim of our study was to investigate the relationship between 1) endocrinologic parameters during pregnancy (serum placental lactogen - HPL, urinary estriol - E3), 2) the occurrence of fetal distress during labor, and 3) the severity of EPH gestosis, and the fetal/placental weight ratio at various gestational ages. The data from a total of 4911 consecutive pregnancies and deliveries were evaluated. Up to 37 weeks the mean fetal/placental weight ratio was significantly lower in infants with fetal distress. Up to 32 weeks there was a positive correlation between the percentage of women with low HPL and E2 levels and the percentage of infants with fetal distress, and the gestosis index. In addition there was a significant increase in the mean fetal/placental weight ratio in the group with moderate and severe gestosis. With advancing gestational age fetal/placental weight ratios were independent of the severity of EPH gestosis. It is concluded that until 37 weeks fetal distress is associated with a significant lower fetal/placental weight ratio. The morphologic and functional changes in placentas of gestotic pregnancies do not manifest themselves in either an increase or a decrease of the mean fetal/placental weight ratio after 33 weeks.

UI MeSH Term Description Entries
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D010925 Placental Function Tests Methods used for the assessment of placental function. Fetoplacental Function Tests,Fetoplacental Function Test,Function Test, Fetoplacental,Function Test, Placental,Function Tests, Fetoplacental,Function Tests, Placental,Placental Function Test,Test, Fetoplacental Function,Test, Placental Function,Tests, Fetoplacental Function,Tests, Placental Function
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D005316 Fetal Distress A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters. Nonreassuring Fetal Status,Fetal Status, Nonreassuring
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

P Riss, and W Bartl
January 1999, Gynecologic and obstetric investigation,
P Riss, and W Bartl
January 2016, Proceedings of the National Academy of Sciences of the United States of America,
P Riss, and W Bartl
May 1984, American journal of obstetrics and gynecology,
P Riss, and W Bartl
March 1992, BMJ (Clinical research ed.),
P Riss, and W Bartl
April 1992, BMJ (Clinical research ed.),
P Riss, and W Bartl
April 1992, BMJ (Clinical research ed.),
P Riss, and W Bartl
January 2018, International journal of medical sciences,
P Riss, and W Bartl
August 2000, Molecular human reproduction,
Copied contents to your clipboard!